Answers are grounded in this paper and cite their sources.
Two new enantioselective syntheses of the naphthopyranquinone antibiotic frenolicin B (1), of its enantiomer 2, and of its diastereoisomers 3 and 4 were accomplished using two different routes from optically active β‐Hydroxy esters (R)‐ and (S)‐11 and 18. β‐Hydroxy esters (R)‐ and (S)‐11 were prepared stereoselectively from optically active sulfenylacetates (S)‐ and (R)‐10, respectively (Scheme 2, Method A). Alternatively, compound 18 was obtained in excellent yield by enantioselective hydrogenation of the corresponding β‐keto ester 17, using a chiral ruthenium‐complex catalyst (Scheme 3, Method B). Subsequently, compounds (S)‐11 and 18 were transformed into frenolicin B (1). In analogy, Stereoisomers 2–4 were prepared from (S)‐ and (R)‐11 in good yields.
No takes yet. Share an insight, caveat, or question.
Masquelin et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: